Wordt geladen...
Dual Inhibition of MAPK and JAK2/STAT3 Pathways Is Critical for the Treatment of BRAF Mutant Melanoma
BRAF and MEK inhibitors significantly prolong progression-free survival in patients with BRAF mutant melanoma. However, most patients quickly develop drug resistance. The mechanism of drug resistance is complicated and remains to be further explored. Here, we found that inhibition of the MAPK pathwa...
Bewaard in:
| Gepubliceerd in: | Mol Ther Oncolytics |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Gene & Cell Therapy
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7330142/ https://ncbi.nlm.nih.gov/pubmed/32637584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2020.06.004 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|